DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Wilding J, Fernando K, Milne N. et al.
SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice.
Diabetes Ther 2018;
9: 1757-1773
We do not assume any responsibility for the contents of the web pages of other providers.